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cADPR is a well-recognized signaling molecule by
modulating the RyRs, but considerable debate exists
regarding whether cADPR can bind to and gate the
TRPM2 channel, which mediates oxidative stress
signaling in diverse physiological and pathological
processes. Here, we show that purified cADPR
evoked TRPM2 channel currents in both whole-cell
and cell-free single-channel recordings and specific
binding of cADPR to the purified NUDT9-H domain of
TRPM2 by surface plasmon resonance. Furthermore,
by combining computational modeling with electro-
physiological recordings, we show that the TRPM2
channels carrying point mutations at H1346, T1347,
L1379, S1391, E1409, and L1484 possess distinct
sensitivityprofiles forADPRandcADPR.These results
clearly indicate cADPR is a bona fide activator at the
TRPM2 channel and clearly delineate the structural
basis for cADPR binding, which not only lead to a bet-
ter understanding in the gating mechanism of TRPM2
channel but also shed light on a cADPR-induced
RyRs-independent Ca2+ signaling mechanism.
INTRODUCTION
Nicotinamide adenine dinucleotide (NAD+), a well-known
enzyme cofactor, and its metabolites have emerged as key
regulators of cellular and organismal homeostasis. Being a3684 Cell Reports 27, 3684–3695, June 18, 2019 ª 2019 The Author(
This is an open access article under the CC BY license (http://creativemajor component of both bioenergetic and signaling pathways,
NAD+ is ideally suited to regulate metabolism and major cellular
events. Recent studies indicate that NAD+ and its metabolites,
including adenosine 50-diphosphoribose (ADP-ribose), cyclic
ADP-ribose (cADPR), and nicotinic acid adenine dinucleotide
phosphate (NAADP) also function in cellular signaling by regu-
lating many Ca2+-permeable ion channels (Gasser et al., 2006;
Koch-Nolte et al., 2008; Lee et al., 1995; Rusinko and Lee,
1989). For example, ADPR can trigger extracellular Ca2+ entry
via activation of the plasma membrane cation channel transient
receptor potential melastatin 2 (TRPM2) (Guse, 2015; Sumoza-
Toledo and Penner, 2011); and NAADP activates the two-pore
channels in the endolysosomes (Guse, 2015; Lee, 2012; Morgan
and Galione, 2014; Patel et al., 2010).
cADPR is another important NAD+ metabolite that has been
recognized as a second messenger in a wide variety of cellular
processes, includingmuscle contraction, release of insulin, secre-
tion of neurotransmitters, and fertilization of oocytes (Bruzzone
et al., 2007; Galione et al., 1991; Guse, 2004; Lee et al., 1989).
It mediates Ca2+ signaling pathways by binding to FKBP12.6
and modulating the function of the ryanodine receptors (RyRs)
(Bultynck et al., 2001; Noguchi et al., 1997; Tang et al., 2002).
However, when RyRs were specifically blocked by a scorpion
toxin, cADPR was still able to induce an increase in the intracel-
lular Ca2+ concentrations in rabbit skeletal muscles, indicating
that RyRs-independent mechanisms contribute to cADPR-
induced Ca2+ responses (Morrissette et al., 1993). Moreover,
cADPR can regulate Ca2+ influx through Ca2+-permeable chan-
nels in neutrophils (Partida-Sa´nchez et al., 2001) and induce the
Ca2+ spikes in T lymphocytes that were blocked by removal of
extracellular Ca2+ or by perfusion with Zn2+ (Guse et al., 1997).s).
commons.org/licenses/by/4.0/).
(legend on next page)
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Therefore, in addition to Ca2+ release via RyRs, cADPR has been
demonstrated to evoke extracellular Ca2+ entry, for which the
TRPM2 channel has gained increasing attention.
The TRPM2 channel is a Ca2+-permeable cation channel
(Jiang et al., 2010) that functions as a sensor of oxidative stress
resulting from an imbalanced redox state that leads to elevated
reactive oxygen species (ROS) levels. Because increasing evi-
dence supports a causative relationship between elevated
ROS and a variety of disease conditions, such as diabetes,
ischemia, neurodegeneration, and cancer (Chen et al., 2014;
Kim et al., 2015; Manna et al., 2015; Ye et al., 2014; Jiang
et al., 2018), to understand how the TRPM2 channel is gated
by ligands is of great importance. The NUDT9 homology
(NUDT9-H) domain in the C terminus of the TRPM2 channels is
essential for binding of NAD+ metabolites and thereby channel
activation (Beck et al., 2006; Csana´dy and To¨rocsik, 2009;
Hara et al., 2002; Kolisek et al., 2005; Lange et al., 2008; Perraud
et al., 2001; Sano et al., 2001; To´th and Csana´dy, 2012). Accu-
mulating evidence indicates TRPM2 is a complex molecular ma-
chine crosslinked to several signaling pathways, uniquely linking
the adenine nucleotide metabolic network to the intracellular
redox status. So, it is critical to clarify the endogenous ligands
from the NAD+ metabolites that gate the TRPM2 channel.
Early studies reported that NAD+ metabolites, including
cADPR, activate the TRPM2 channel (Beck et al., 2006; Kolisek
et al., 2005; Lange et al., 2008). However, recent studies have
challenged that view and suggested that those earlier results
might be compromised by ADPR contamination in the commer-
cial cADPR (To´th and Csana´dy, 2010; To´th et al., 2015). There-
fore, whether cADPR acts as a ligand for direct binding and
activation of the TRPM2 channel is crucial to fully understanding
the Ca2+ signaling mechanisms that it mediates.
Here, through a combination of surface plasmon resonance
(SPR), whole-cell and single-channel patch-clamp recordings,
cADPR-hydrolase activity assays, site-directed mutagenesis,
and computational modeling, we investigated whether cADPR
is a true ligand for the TRPM2 channel. Our results clearly
demonstrate that cADPR is a bona fide activator of the TRPM2
channel. Furthermore, we have determined the key residues
within the NUDT9-H domain that interact with cADPR and have
revealed distinct modes of binding for cADPR and ADPR to the
TRPM2 channel.Figure 1. cADPR Directly Activates and Binds to the TRPM2 Channel
(A) Chemical structure of cADPR.
(B) Analysis of synthesized cADPR using TLC with a C18 silica gel plate. The com
(C) Representative TRPM2 channel current traces induced by 500 mM cADPR in T
whole-cell configuration.
(D) The concentration-current response relationship for cADPR and the wild-typ
pendent preparations. All of the concentration-current response relationships for
line for comparison.
(E) Representative TRPM2 channel current traces induced by 10 mM cADPR in W
37C. The inset represents a summary of the currents.
(F) Representative single-channel recordings in TRPM2-expressing HEK293 cell
(G) The open probability of single-TRPM2 channels activated by 100 mM of ADPR
minimum and maximum values; horizontal bars represent medians. ns, no signifi
(H and I) SPR curves of cADPR (H) and ADPR (I) binding to NUDT9-H (left) and t
described in the Method Details and determined according to three parallel expe
See also Figures S1 and S2.
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cADPR Directly Activates and Binds to the TRPM2
Channel
The structure of cADPR comprises three moieties: a northern
ribose, a pyrophosphate, and an adenosine (Figure 1A). To
exclude ADPR contamination in commercially available cADPR,
as previously reported (To´th and Csana´dy, 2010), we synthe-
sized cADPR by previously established protocols (Lee and
Aarhus, 1991). Thin-layer chromatography (TLC) analysis
showed a single, distinct spot for synthesized cADPR, indicating
no detectable ADPR contamination (Figure 1B). Like ADPR, with
whole-cell recordings in HEK293 cells expressing the human
TRPM2 channel, cADPR clearly induced large TRPM2 currents
(Figure 1C) that were strongly inhibited by acidic pH 5.0 at
room temperature, as shown in our previous studies (Yang
et al., 2010). Although the amplitudes of the maximal currents
induced by cADPR and ADPR were similar, the 50% effective
concentration (EC50) value for cADPR (251.1 ± 17.8 mM) was
greater than that for ADPR (40.0 ± 4.5 mM) (Figure 1D), which is
in agreement with previous reports (Beck et al., 2006; Kolisek
et al., 2005). Similar to previous studies (Togashi et al., 2006),
cADPR at 10 mM, which is close to its physiological concentra-
tion, also induced the TRPM2 channel currents at 37C (Fig-
ure 1E). To exclude the possibility that cADPR activated the
TRPM2 channel through intracellular signaling, we recorded in
the inside-out configuration single-channel activity in cell-free-
excised membrane patches and found that cADPR elicited
single-channel opening in a similar fashion as that of ADPR (Fig-
ures 1F and 1G). Taken together, these results provide evidence
to demonstrate that cADPR is an agonist that can directly gate
the TRPM2 channel.
Then, to approach the question of whether cADPR binds to the
ADPR-binding pocket formed by the NUDT9-H domain, we
purified the NUDT9-H domain from Rosetta (DE3). To improve
the poor solubility of the NUDT9-H protein in Tris solution, as
previously reported (Iordanov et al., 2016; To´th et al., 2014),
N-dodecyl-b-D-maltoside (DDM) detergent was added to facili-
tate analysis of the binding affinities of this protein for cADPR,
ADPR, and NAD+ by the SPR technique (Figures S1A and
S1B). We clearly observed that cADPR bound to the NUDT9-H
protein in a concentration-dependent fashion, with a dissociationmercial ADPR was used as a control.
RPM2-expressing HEK293 cells (black) at80 mV at room temperature. W.C.,
e (WT) TRPM2 channel. Data are expressed as means ± SEM from five inde-
ADPR reported in our previous work are marked in this article as the red dotted
T (red, n = 4 cells) and TRPM2-expressing (black, n = 5 cells) HEK293 cells at
s exposed to 100 mM of ADPR (top) and 500 mM of cADPR (bottom).
(n = 7 patches) and 500 mM of cADPR (n = 6 patches). Whiskers extend to the
cant difference.
he representative binding curve (right). All binding affinity values are tested as
riments.
Figure 2. The Activity and Protein Expres-
sion of cADPR Hydrolases Are Not Detect-
able in HEK293 Cells
(A) The cADPR-hydrolase activity of the lysates
from HEK293 cells (top) and CD38-overexpressing
HEK293 cells (bottom).
(B) Quantitation of the relative contents of cADPR
(top) and ADPR (bottom) at different time points in
the reaction in (A).
(C and D) Immunostaining followed by flow cy-
tometry to analyze the expression of CD38 (C) and
CD157 (D) in HEK293 cells. Serving as positive
controls, HEK293 cells were transfected with
pcDNA3.1-CD38 (C) or pCMV3-CD157 (D) before
analysis. The cells were briefly treated with 0.01%
trypsin-EDTA for cell detachment andwere stained
with primary antibodies, anti-CD38 (C) or anti-
CD157 (D). The dot plots (left panel) and histo-
grams (right panel) of the flow cytometry analyses
are shown.constant (KD) of 11.53 ± 5.8 mM (Figure 1H). As a positive control,
our SPR results showed that ADPR bound to the NUDT9-H
protein (KD = 70.2 ± 10.0 mM) (Figure 1I). By contrast, NAD
+ did
not bind to the NUDT9-H domain (Figure S1C), confirming the
notion that NAD+ does not act as a TRPM2 channel agonist (Yu
et al., 2017).
cADPR Is Not Converted into ADPR in HEK293 Cells
Cluster of differentiation 38 (CD38) and CD157 belong to an
evolutionarily conserved ADP-ribosyl cyclase gene family and
have crucial roles in the reciprocal transformation of cADPR,
NAADP, and ADPR (Graeff and Lee, 2013). To eliminate the
possibility that cADPRwas converted to ADPRby these enzymes
and thereby activated the TRPM2 channel in HEK293 cells, com-
mercial cADPR was first purified using high-performance liquid
chromatography (HPLC) (Figure S2A). We found that cADPR
was not contaminated by ADPR as identified by mass spectros-
copy (MS) (Figures S2B and S2C). Then cADPR-hydrolase activ-
ity assays (Munshi et al., 2000) showed that lysates of HEK293Cell Rcells overexpressing CD38 hydrolyzed all
cADPR into ADPR within 0.5 h, whereas
lysates from wild-type (WT) or blank
HEK293 cells did not decrease the cADPR
peak even after 2 h, which was much
longer than the duration of electrophysio-
logical recordings (Figures 2A and 2B).
These results indicate that WT HEK293
cells do not contain any detectable
cADPR-hydrolase activity.
We further quantified the amount of
cell-surface CD38 and CD157 in HEK293
cells by flow cytometry, followed by im-
munostainingwith the specific antibodies.
As shown in Figure 2C, the signal of
anti-CD38 staining (middle dot plot, blue
histogram) was basically identical to the
negative control (2nd antibody only, leftdot plot, red histogram), although the cells transfected with
CD38-expression plasmid showed significant anti-CD38 anti-
body staining (right dot plot, orange histogram). Similar results
were obtained in WT and CD157-overexpressing HEK293 cells
by anti-CD157 staining (Figure 2D). These results further demon-
strate that HEK293 cells express neither CD38 nor CD157 or
that the expression levels are below the detection by immuno-
staining, which excluded the possibility that cADPR indirectly
activates the TRPM2 channel in HEK293 cells via enzymatic con-
version to ADPR.
Molecular Docking and Molecular Dynamics (MD)
Simulation Predict Binding of cADPR to the ADPR-
Binding Pocket
Recent studies reported the structures of the sea anemone
(Nematostella vectensis [nv]) TRPM2, zebrafish (Danio rerio)
TRPM2, and human TRPM2 (Huang et al., 2018; Wang et al.,
2018; Zhang et al., 2018). Although the structure of human
TRPM2 in an ADPR-bound state has been resolved (Zhangeports 27, 3684–3695, June 18, 2019 3687
Figure 3. L1379, G1389, and E1409 in the
NUDT9-H Domain Are Predicted to Interact
with the Northern Ribose of cADPR
(A) Ribbon presentation of the northern ribose-
binding pockets in theNUDT9-Hdomain (gray). The
interactions are denoted with yellow dashed lines.
(B) Summary of the TRPM2 channel currents
induced by EC10 (gray) and EC90 (black) concen-
trations of cADPR.
(C and D) Characterization of the cADPR
concentration–current response relationship curves
forWT (blackdashed line) andmutantsofL1379S (C)
and E1409Q (D) of the TRPM2 channels (black
continuous line).
All data are expressed as means ± SEM from five
independent repeats. *p < 0.05, ***p < 0.001
versus WT.et al., 2018), the binding pattern in this structure (6MIZ) is still un-
known.We recently reported a subset of residues in the NUDT9-
H domain to be critical in defining the ADPR-binding pocket at
the TRPM2 channel (Yu et al., 2017). To further reveal the nature
of cADPR binding to the NUDT9-H domain, similar molecular
docking of cADPR, together withMD simulation, was conducted
(Yu et al., 2017). The results predicted the same subset of resi-
dues interact with both cADPR and ADPR (Figure S3). More spe-
cifically, L1379, G1389, and E1409 interact with the northern
ribose; H1346, T1347, S1391, and R1433 interact with the pyro-
phosphate group; and T1349, D1431, L1484, and H1488
interact with the adenosine base (Figure S3A). We further per-
formed 15-ns equivalent simulations of the NUDT9-H with
cADPR bound and examined each of the structurally identical
binding sites with different ligands. The root-mean-square devi-
ations (RMSDs) of the protein backbone atoms for the complex
reached equilibrium after 9 ns at 4 A˚ for the cADPR-NUDT9-H
complex (Figure S3B). We calculated, based on the frames
from a 13- to 15-ns MD simulation trajectory, the total binding
energy of cADPR binding (Table S1) and, moreover, the contri-
butions of the 11 residues to the binding energy for cADPR,
and assigned them into Van derWaals (VDW) force, electrostatic
interaction, polar solvation, and non-polar solvation groupings
(Tables S2). Although many residues exhibited similar energy
contribution profiles for their interactions with cADPR and
ADPR, the interaction patterns at several residues were pre-
dicted to be distinct between the two ligands, including
H1346, T1347, and E1409. Such information supports the idea
that these residues interact strongly with both ADPR and cADPR
and that, as a ligand of the TRPM2 channel, cADPR has a bind-
ing configuration distinct from ADPR. So, we next performed a
mutagenesis study to functionally analyze their types of interac-
tion with, and involvement in, the TRPM2 channel activation by
cADPR.3688 Cell Reports 27, 3684–3695, June 18, 2019Mutations of Key Residues
Interactingwith theNorthernRibose
Group Enlarge the Difference in the
Sensitivity to ADPR and cADPR
L1379, G1389, and E1409 were predicted
to interact with the northern ribose ofcADPR (Figure 3A). L1379 was predicted to interact with this
part via VDW forces (Table S2). L1379A mutation to shorten
the side chain of Leu significantly reduced the currents induced
by 500-mM cADPR (Figure 3B; p = 0.017). In addition, introduc-
tion of a polar group with L1379S mutation decreased the sensi-
tivity to cADPR (Figure 3C). These results suggest that not only
the VDW force but also a non-polar solvation interaction have
important roles in the interactions with L1379.
For G1389, our MD simulation suggests occurrence of an elec-
trostatic interaction between its carboxyl group and the hydroxyl
group of the northern ribose ring of cADPR. We found none of
G1389A, G1389E, and G1389D mutant channels was activated
by cADPRat 500 mM (Figure 3B) or evenat 3mM (data not shown),
whichpreventedus fromconstructing theconcentration-response
relationship curve. These results are similar to those for ADPR (Yu
et al., 2017) and, overall, support the notion that the position of
G1389 is critically required for cADPR-induced TRPM2 activation.
E1409 was predicted to have an electrostatic interaction be-
tween its hydroxyl oxygen atom and cADPR (Table S2), which
is different from ADPR, which has a strong polar-solvation inter-
action with this residue (Yu et al., 2017). Consistent with this
notion is that E1409Q mutation decreased the sensitivity to
ADPR but increased the sensitivity to cADPR (Figure 3D; Table
S3). These distinctive mutational effects likely result from exclu-
sive impairment in the electrostatic interaction, indicating the
importance of the electrostatic interaction between this residue
and the terminal ribose of cADPR and supporting the hypothesis
that cADPR have a distinct interaction configuration from ADPR.
Mutations of Key Residue Interacting with the
Pyrophosphate Group Reverse the EC50 Values of ADPR
and cADPR
Our MD simulation identified H1346, T1347, S1391, and R1433
as key residues that interact with the pyrophosphate group of
Figure 4. H1346, T1347, S1391, and R1433 of
the NUDT9-H Domain Are Key Residues
That Interact with the Pyrophosphate Group
of cADPR
(A) Ribbon presentation of the pyrophosphate
group binding pockets in the NUDT9-H domain
(gray). The interactions are denoted with yellow
dashed lines.
(B–D)Characterization of the cADPRconcentration–
current response relationship curves for WT (black
dashed line) and mutants of H1346W (B), T1347Y
(C), and R1433G (D) of the TRPM2 channels (black
continuous line).
(E) Summary of the currents induced by EC10
(gray) and EC90 (black) concentrations of cADPR.
Data are expressed as means ± SEM from five
independent repeats. *p < 0.05, ***p < 0.001
versus WT.cADPR (Figure 4A). For H1346, an electronic interaction was pre-
dicted (Table S2). Our mutagenesis results showed that neither
theH1346AnorH1346Fmutant responded to cADPR (Figure 4E),
suggesting that the electronic interaction mediated by the imid-
azole ring of H1346 is critical for cADPR binding. In contrast, the
H1346Wmutant not only showed increased sensitivity to cADPR
(Figure 4B; Table S3) but also changed its Hill slope (Table S3),
supporting the idea that replacement with a benzene ring by
this mutation facilitates the interactions between cADPR and
this residue and the gating process. Of note, although H1346A
and H1346F mutations caused similar change in the sensitivity
to both cADPR and ADPR, the H1346W mutation resulted in
opposite effects on channel activation by these two ligands,
illustrating their difference in electrostatic interactions with
H1346.
Another residue that had clearly different types of interactions
in our previous MD simulation was T1347, which was predicted
to have a polar-solvation interaction with cADPR (Table S2) but
an electrostatic interaction with ADPR (Yu et al., 2017). Neither
the mutants T1347A and T1347I, which would disrupt the po-Cell Rlar-solvation interaction, nor the T1347S
mutant, which would change the spatial
location of polar-solvation interaction,
was activated by cADPR (Figure 4E).
The T1347F mutant, although it lost the
polar-solvation interaction, still had an
equivalent activation to the WT channel
at both EC10 and EC90 concentrations of
cADPR (Figure 4E) through an interaction
with the introduced benzene ring of Phe.
Interestingly, the T1347Y mutation, which
slightly reduced the sensitivity to ADPR
(Yu et al., 2017), strongly increased the
sensitivity to cADPR (Figures 4C and 4E;
p = 0.029; Table S3). This result may be
due to a more prone position for the
polar-solvation interaction between the
hydroxyl group of this residue and cADPR
when a benzene ring was introduced, alsosuggesting the different gating modes of cADPR and ADPR at
this residue.
For S1391, although the MD simulation did not predict a sub-
stantial difference between cADPR and ADPR (Table S2), none
of the mutations introduced into S1391 (S1391A, S1391F, and
S1391Y) altered the sensitivity for cADPR (Figure 4E), whereas
the S1391A mutant had a dramatically decreased EC50 for
ADPR (Yu et al., 2017). In addition, the S1391T mutant, which
introduced a methyl group and would change the direction of
the hydroxyl group, was not activated by cADPR (Figure 4E),
highlighting the importance of both presence and spatial position
of the electrostatic interaction provided by the hydroxyl group of
S1391.
A large contribution of polar-solvation interaction was pre-
dicted at R1433 (Table S2). Introduction of the R1433A mutation
that disrupted the polar group resulted in amutant channel with a
much higher EC50 for cADPR (Figure 4E; Table S3); and the mu-
tants with R1433K and R1433Q, which both changed the group
that provided the polar-solvation interaction, were not activated
by cADPR (Figure 4E), even at a high concentration of 3mM (dataeports 27, 3684–3695, June 18, 2019 3689
Figure 5. Y1349, D1431, L1484, and H1488
Residues in the NUDT9-H Domain
Contribute to Interactions with the Adeno-
sine Group of cADPR
(A) Ribbon presentation of the adenosine group
binding pockets in the NUDT9-H domain (gray).
The interactions are denoted with yellow dashed
lines.
(B–D)Characterizationof thecADPRconcentration–
current response relationship curves for WT (black
dashed line) and indicatedmutant TRPM2 channels
(black continuous line).
(E) Summary of the currents induced by EC10
(gray) and EC90 (black) concentrations of cADPR.
Data are expressed as means ± SEM from five
independent repeats. *p < 0.05, ***p < 0.001
versus WT.not shown). However, the R1433Gmutant, with a shortened side
chain length but still able to form a polar-solvation interaction,
had a higher, but non-saturating, EC50 (Figure 4D; Table S3).
These results demonstrate a strict requirement for the polar-sol-
vation interaction at R1433.
Mutations of Key Residue Interacting with the
Adenosine Group Impair the Channel Activation by
ADPR and cADPR
The MD simulations predicted that Y1349, D1431, L1484, and
H1488 residues contribute to interactions with the adenosine
group of cADPR (Figure 5A). Similar contributions of polar-solva-
tion interaction and VDW force were predicted for Y1349 (Table
S2). In our functional assays, none of the mutants that changed
the side chain length, nomatter whether they preserved the polar
group (Y1349A, Y1349S, and Y1349W), were activated by
cADPR (Figure 5E). On the contrary, the mutants Y1349F and
Y1349I, which lost the polar-solvation interaction but kept the3690 Cell Reports 27, 3684–3695, June 18, 2019VDW groups, were activated by cADPR
with a similar (Y1349F) or higher (Y1349I)
EC50 (Figures 5B and 5E; Table S3), sug-
gesting a major contribution of VDW force
from this residue.
Our simulation predicted a strong elec-
trostatic interaction between D1431 and
cADPR (Table S2). This was supported
by the mutagenesis results showing that
the D1431A mutant almost failed to
respond to cADPR, whereas the D1431N
mutant had amuchhigher EC50 for cADPR
than that of the WT channel (Figure 5E;
Table S3). Furthermore, the D1431E
mutant with a longer side chain was also
not activated by cADPR (Figure 5E). These
results suggest that the electrostatic
interaction of D1431 and its proper orien-
tation are necessary for cADPR-induced
TRPM2 channel activation.
In addition, a polar-solvation interaction
was predicted for both L1484 and H1488residues (Table S2). In the case of L1484, the L1484S mutant, in
which a new polar group was introduced, was not activated by
cADPR (Figure 5E). However, changing the spatial configuration
of the side chain in the L1484V mutant resulted in a slight right-
shift of the dose-response curve (Figure 5C and 5E; p = 0.013;
Table S3), which indicates that the VDW force also has a role
in the binding of cADPR to this residue. For H1488, the
H1488Fmutant, which lost the polar group, had a reduced sensi-
tivity to cADPR (Figure 5D). However, although the polar-solva-
tion interaction was preserved in the H1488W mutant, the steric
hindrance caused by the benzene ring in this mutant made it un-
responsive to cADPR (Figure 5E). These results provide evidence
to support the idea that H1488 is critical for cADPR to activate
the TRPM2 channel.
Our above results indicate ADPR and cADPR bind to the same
pocket and, further, identify six residues that exhibit different in-
teracting patterns between cADPR and ADPR. The E1409Q mu-
tation resulted in the most distinct effect on the TRPM2 channel
Figure 6. Residues That Exhibit Different Interacting Patterns between cADPR and ADPR
(A and B) The SPR curves of cADPR (A) and ADPR (B) binding to NUDT9-H-E1409Q (left) and the representative binding curve (right). All binding affinity values are
determined according to three parallel experiments.
(C and E) Representative whole-cell TRPM2 channel current traces induced by 100 mM of cADPR without or with prior incubation with reCD38 in HEK293 cells
expressing WT TRPM2 (C) and T1347Y mutant channel (E).
(D) Summary of the currents induced in (C) (n = 5 cells). Data are expressed as means ± SEM. **p < 0.01, ***p < 0.001.
(F) Summary of the currents in (E) (n = 5 cells). Data are expressed as means ± SEM. **p < 0.01, ***p < 0.001.
(legend continued on next page)
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activation by ADPR and cADPR (Figure 3D). To further determine
whether the E1409Q mutant changed the binding affinity of both
ADPR and cADPR, we performed the SPR assay on the purified
NUDT9-H E1409Q protein. The KD value for cADPR was remark-
ably increased (1,114.0 ± 0.1 mM), whereas the binding affinity
for ADPR was only slightly increased (KD = 31.2 ± 4.4 mM) (Fig-
ures 6A and 6B), showing that this mutation resulted in a strong
difference in altering the binding affinity for cADPR and ADPR,
which is consistent with the electrophysiological results. There-
fore, our data show that the binding affinity for cADPRwas higher
than ADPR, but the EC50 for ADPR in inducing TRPM2 activation
was less than that for cADPR, which suggests that, upon bind-
ing, cADPR induces conformational changes to open the
TRPM2 channel in a manner different from that of ADPR.
Besides E1409Q, T1347Y is another mutant that reversed the
effects of ADPR and cADPR on TRPM2 activation. We further
tested the effects of 100 mM of cADPR incubated without or
with recombinant CD38 (reCD38) for 135 min on both WT
TRPM2 and T1347Y mutant channels using whole-cell record-
ings. The sample composition after reCD38 incubation, analyzed
by HPLC, showed that about half of the cADPRwas converted to
ADPR (Figure S4). Accordingly, 100 mM of cADPR after incuba-
tion with reCD38 significantly induced a larger WT TRPM2 chan-
nel current than did the sample without incubation (Figures 6C
and 6D), but it induced a dramatically smaller current mediated
by the mutant T1347Y channel than did the sample with incuba-
tion (Figures 6E and 6F). Furthermore, we compared the
responses of WT and mutant T1347Y TRPM2 channels to
100 mM cADPR and ADPR in the same patch in single-channel
recordings (Figures 6G and 6H). Consistent with the results in
whole-cell recording (Figure 4C), the open probability of the
WT channel induced by cADPR versus ADPR was the opposite
of that of themutant T1347Y channel at single-channel level (Fig-
ures 6I and 6J). Taken together, these results confirm the impor-
tant role of T1347 in different binding modes of cADPR and
ADPR in the NUDT9-H domain.
DISCUSSION
To identify the endogenous ligands for the TRPM2, it is critical to
uncover themolecular basis for their binding to this channel. Here,
we provide several lines of independent evidence using different
techniques that consistently demonstrates that cADPR,an impor-
tant messenger evoking Ca2+ signaling, can directly interact with,
and open, the TRPM2 channel. In this study, we purified cADPR
that showed no detectable trace of ADPR (Figures 1B and S2).
With such purified cADPR, functional assays demonstrated that
several mutants, including H1346W, L1347Y, L1379S, S1391A,
E1409Q, and L1484V, had different sensitivity for ADPR versus
cADPR. Single-channel recording and cADPR-hydrolase activity(G and H) Representative single-channel recordings in cells expressing WT (G) a
100 mM of ADPR on the same patch.
(I) Analysis of single-channel open probability for (G) (n = 5 patches). Whiskers ex
**p < 0.01.
(J) Analysis of single-channel open probability for (n = 4 patches). Whiskers exten
no significant difference.
See also Figure S4.
3692 Cell Reports 27, 3684–3695, June 18, 2019assays further excluded the possibility that cADPR activated the
TRPM2 channel by converting to ADPR by ADP-ribosyl cyclases.
Moreover, the results from SPR assays clearly indicate that
cADPRbinds to theNUDT9-Hdomain of TRPM2. Taken together,
our results notonlydemonstrate that cADPRactivates theTRPM2
channel (Kolisek et al., 2005; Togashi et al., 2006) but also estab-
lish that cADPRbinds to the samepocket asADPRdoes. Amodel
of cADPR binding to this pocket in the NUDT9-H domain is
presented in Figure 7, and the key residues we identified here
are shown as green in Figure 7C. The different interactions at six
residues between cADPR and ADPR further confirm that cADPR
is, in fact, a ligand of the TRPM2 channel.
To activate the TRPM2 channel, a ligand needs to bind to the
NUDT9-H domain and to induce conformational changes to
open the channel pore. Generally, the EC50 value provides an
indication of the capacity of these two distinctive processes in
combination, whereas the SPR results mainly reflect only ligand
binding. In our study, although the EC50 value of cADPR was
much higher than that of ADPR for TRPM2 activation, the SPR
results showed that the binding affinity of cADPR was higher
than that of ADPR to the NUDT9-H domain, which may indicate
the ability of cADPR to induce gating conformational changes is
weaker than that of ADPR. Because cADPR has a glycosidic
bond that locks its structure, ADPR is more flexible than cADPR
is. Such structural flexibility in ADPR may facilitate induction of
conformational changes and result in a lower EC50 value than
that of cADPR. Moreover, our mutagenesis functional assays
provided the supporting evidence: (1) mutation of Y1349,
D1431, L1484, and H1488 residues, which interact with the
adenosine group of cADPR and ADPR, markedly increased the
EC50 values of both ADPR and cADPR, activating the TRPM2
channel, suggesting that the contributions of the adenosine
group in ADPR and cADPR in the TRPM2 channel activation
are similar; and (2) the residues, with the mutations exhibiting
different interacting patterns between cADPR and ADPR, all
interact with the terminal/northern ribose (L1379 and E1409) or
the pyrophosphate group (H1346 and T1347) of ADPR and
cADPR. These results suggest that the terminal/northern ribose
and pyrophosphatemoieties, which are important in determining
the differential structural flexibility of cADPR and ADPR, might
result in distinct sensitivity and gating properties of the TRPM2
channel.
On the other hand, despite several structures of TRPM2 being
determined to show the overall architecture of this channel,
these recent structural works have not revealed the ligand bind-
ing and gating mechanisms of the TRPM2 channel because (1)
the structure of nv TRPM2 contains no intracellular domain,
providing no information of ADPR binding (Zhang et al., 2018);
(2) a recent study has resolved the structure of zebrafish
TRPM2 by Cryo-electron microscopy (EM) where another ligandnd T1347Y mutant (H) TRPM2 channel in response to 100 mM of cADPR and
tend to the minimum and maximum values; horizontal bars represent medians.
d to the minimum and maximum values; horizontal bars represent medians. ns,
Figure 7. Structural Model of cADPR Binding to the NUDT9-H
Domain Presented from Different Orientations
(A and B) Side (A) and top (B) view of cADPR binding in the NUDT9-H domain.
The positively and negatively charged residues are, respectively, colored in
blue and red.
(C) The whole view of the binding pocket of cADPR in the NUDT9-H domain.
Critical residues for binding are labeled in green.binding site exists in its N terminus (Huang et al., 2018); and (3)
the structure of the human TRPM2 channel in the presence of
ADPR has been resolved, but the binding pocket or key residues
have not been defined (Wang et al., 2018). In addition, our recent
study has shown the TRPM2 activation requires both intracel-
lular calcium binding to its N terminus and ADPR acting on its
C terminus (Luo et al., 2018). These studies all suggest the
complexity of TRPM2 activation induced by the ligands.
Because it is still unclear whether the N terminus of TRPM2 is
involved in ADPR- and cADPR-induced TRPM2 activation, it
will be interesting to determine the binding properties of these
ligands to the N terminus and to uncover the relationship be-
tween the ligand binding sites on the N and C termini of
TRPM2 for ligand-induced channel activation in the future.
Meanwhile, to address these critical issues might be helpful in
understanding why there are differential patterns between the
binding affinities and EC50 values of ADPR versus cADPR.cADPR has been widely recognized as a signaling molecule in
species ranging from plants to mammals. To date, most studies
have reported that cADPR increases the intracellular Ca2+ levels
through activating the RyRs. A previous study also reported that
cADPR at physiological conditions activated the TRPM2 channel
(Togashi et al., 2006). Consistently, our data showed cADPR
close to the physiological concentration was able to induce
TRPM2 channel activation at body temperature, supporting the
idea that TRPM2 is involved in cADPR-mediated intracellular
Ca2+ signaling in many physiological and pathological pro-
cesses. Although a recent study argues that cADPR is not an
endogenous ligand of the TRPM2 channel (To´th et al., 2015),
our results provide clear evidence to support the earlier studies
showing that cADPR is, indeed, a ligand that gates the TRPM2
channel. Our finding is also consistent with one of our earlier
reports in which cIDPRE, a synthetic cADPR analog that is resis-
tant to CD38 hydrolytic activity, activates the TRPM2 channels
endogenously expressed in Jurkat T cells and exogenously ex-
pressed in HEK293 cells (Yu et al., 2012). In that study, we also
reported that both RyR2 and RyR3 mediated the early phase
of cADPR-induced Ca2+ responses, whereas the TRPM2 chan-
nel was responsible for the late and sustained phase in Jurkat
T cells. These studies imply that both the RyRs and TRPM2
channels are responsible for cADPR-induced Ca2+ signaling.
An attractive and reconciling hypothesis is that cADPR induces
initial Ca2+ release via the RyRs and subsequently, in synergy
with intracellular Ca2+, evokes extracellular Ca2+ influx via the
TRPM2 channel to generate a sustained Ca2+ signaling.
In summary, our results reveal TRPM2asan identified target for
cADPR, which directly activates this channel by binding to the
same pocket as ADPR in the NUDT9-H domain but via distinct
interactions. It will be very valuable to investigate the contribution
of the TRPM2 channel in cADPR-mediated intracellular Ca2+
signaling in a variety of physiological or pathological processes.STAR+METHODS
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pGEX-4T-1-hNUDT9H This paper N/A
pGEX-4T-1-hNUDT9H-G1389A This paper N/A
Software and Algorithms
Docking-Glide Schrodinger 2018-1 https://www.schrodinger.com/
Molecular dynamic simulation AMBER 11 http://ambermd.org/
Data analysis CytExpert https://cytexpert.updatestar.com/
en/technical
Data analysis Flowjo https://www.flowjo.com/
Data analysis Graph Pad Prism 6 https://www.graphpad.com/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Wei Yang
(yangwei@zju.edu.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
HEK293 cells were used to transiently express wild-type andmutant channels. Cells weremaintained in Dulbecco’s modified Eagle’s
medium DMEM supplemented with 50 units/mL penicillin and 50 mg/mL streptomycin (GIBCO, USA) and 10% fetal bovine serum,
and were cultured at 37C under a humidified atmosphere containing 5% CO2. HEK293 cells are originally female in origin and its
transient transfections were performed with Lipofectamine 2000 Transfection Reagent (Invitrogen, USA) according to the manufac-
turer’s protocol
METHOD DETAILS
High performance liquid chromatography (HPLC)
Commercial cADPR was purified with HPLC, which was conducted on a C18 reversed phase column (Vemusil XBP C18, 10 mm,
100 A˚, 10 3 150 mm), eluting with a linear gradient of 0%–60% CH3CN in triethylammonium acetate buffer within 30 min at a
flow rate of 1 mL/min. The column temperature was 20C. The UV detection wavelength was 254 nm.
NAD+ metabolites quantification in the experiments of cADPR hydrolase activity was conducted with HPLC using a 6 3 150 mm
column packed with of AG MP-1 resin (Bio-rad). The nucleotides were eluted with a gradient of Trifluoroacetic acid (TFA). The TFA
gradient was increased gradually from 5 to 30mM in the first 15min to elute cADPR and kept in 30mM for 5min to elute ADPR. HPLC
of NAD+metabolites in the experiments of cADPR hydrolase incubation was also conducted on the same column, and products were
eluted with a gradient of TFA from 0 to 67.5 mM over 22.5 min at a flow rate of 1 mL/min. The column temperature was 20C. The UV
detection wavelength was 260 nm.Cell Reports 27, 3684–3695.e1–e4, June 18, 2019 e2
Electrophysiology
Whole-cell current recordings were performed by using an Axopatch 200B amplifier (Molecular Devices) at room temperature or 37C
as described previously (Yu et al., 2017). Specifically, the extracellular solution contained 147 mM NaCl, 2 mM KCl, 1 mM MgCl2,
2 mM CaCl2, 10 mM HEPES, and 13 mM glucose, pH 7.4. The intracellular solution contained 147 mM NaCl, 0.05 mM EGTA,
1 mM MgCl2, 10 mM HEPES, and cADPR at indicated concentrations, pH 7.3. The membrane potential was held at 0 mV, and a
voltage ramp of 500 ms duration from 100 mV to 100 mV was applied every 5 s. Glass pipettes with a resistance of 3–5 MU
were used. Data were acquired at 10 kHz and filtered offline during data analysis. Change of the extracellular solution was performed
using a RSC-160 system (Bio-Logic Science Instruments).
Single channel recordings were performed using aHEKA EPC10 amplifier controlledwith PatchMaster software (HEKA). Themem-
brane potential was held at 80 mV and currents were elicited by gap-free protocol. The extracellular solution contained 145 mM
NaCl, 5.6 mM KCl, 2 mM MgCl2, 1.2 mM CaCl2, and 10 mM HEPES, pH 7.3. The intracellular solution contained 140mM potassium
gluconate, 4 mM NaCl, 2 mM MgCl2, 10 mM CaCl2, 1 mM EGTA, 10 mM HEPES, and 500 mM cADPR or 50 mM ADPR, pH 7.2.
Data were filtered at 2.25 kHz and sampled at 12.5 kHz. Change of the extracellular solution was performed using a RSC-200 system
(Bio-Logic Science Instruments). Single-channel data was processed by the QuB software version 1.4. Opening and closing events
were detected during idealization with the half amplitude method.
NUDT9-H protein purification
The NUDT9-H domain of human TRPM2 protein (Uniprot O94759) containing a N-terminal glutathione (GST) tag followed by a
thrombin cleavage site was constructed into pGEX-4T-1 vector and heterologously expressed in E. coli strain Rosetta (TransGen
Biotech). Cells were cultured in LB media at 37C until OD600 reached 0.6, followed by addition of isopropylthio-b-D-galactoside
(IPTG) (Invitrogen) to give a final concentration of 0.2 mM. Cells were collected by centrifugation after further incubation for 24 h
at 23C, and cell pellets were resuspended at a concentration of 5-6 mL/g wet weight in Tris-EDTA buffer (20 mM Tris pH 7.4,
0.5 mM EDTA) supplemented with a protease inhibitor cocktail (containing 2 mg/mL DNase I, 0.5 mg/mL pepstatin, 2 mg/mL leupeptin
and 1 mg/mL aprotinin, and 0.1 mM PMSF) and 0.5% N-dodecyl-b-d-maltopyranoside (DDM, Anatrace) and homogenized by
sonication on ice. Then, the supernatant was collected by centrifugation at 14,000 g for 45 min and incubated with gluthathione
Sepharose 4B resin (GE Healthcare) with gentle rotation at 4C. After 3 h, the resin was collected on a disposable gravity column,
incubated for 10minwith 5 bed volumewash buffer (20mMTris pH 7.4, 0.5mMEDTA, 0.025%DDM). TheGST-NUDT9-Hwas eluted
with elution buffer containing 15mM reduced gluthathione (BBI). 4mgGST-NUDT9-Hwas then incubated with 2 U thrombin (GIBCO)
with gentle rotation at 4C for 24 h. The mixture was incubated with gluthathione Sepharose 4B resin again for 3 h. After collecting
the resin on a disposable gravity column, the purified NUDT9-H (with no GST tag) in the flow through was collected. NUDT9-H
were concentrated to over 1 mg/mL using a 10 kDa cut-off concentrator (Vivaspin2 GE Healthcare, 2 mL) and further purified by
size exclusion chromatography on a Superdex 200 10/300 GL column (GE Heathcare) which was pre-equilibrated with wash buffer
(20 mM Tris pH 7.4, 0.5 mM EDTA, 0.025% DDM).
Surface plasmon resonance
Binding affinities of cADPR, ADPR and NAD+ to the NUDT9-H domain of human TRPM2 was determined on a Biacore T200
instrument (BIACORET200, GE, USA). TheNUDT9-H proteinwas immobilized onCM5 sensor chips by an amine-coupling procedure
on flow cells channel 2–4, whereas flow cell 1 served as a negative control. Hundred microliters of a 1:1 mixture of 0.4 M 1-ethyl-3-
(3-dimethyla-minopropyl carbodiimide (EDC) in H2O and 0.1 M N-hydroxysuccinimide (NHS) in H2O were injected at a flow of
30 mL/min for 420 s in order to activate the carbonyl group. The NUDT9-H protein was dissolved in sodium acetate acid buffer
(pH 4.5) at a final concentration of 40 ug/mL with the injection time of 60 s, dissociation time of 60 s, flow rate 30 mL/min. Then,
the sample was blocked with ethanolamine (1 M) in the other unbound regions of the sensor chip with a flow rate of 5 mL/min for
420 s to the final 8000 response units (RU). Sensor chips were primed twice with degassed physiological running buffer (0.02 M
phosphate buffer saline (PBS), 2.7 mM KCl, 137 mM NaCl, 0.05% Surfactant P20, pH 7.4) and equilibrated at 50 mL/min until the
baseline appeared stable. cADPR, ADPR and NAD+ were dissolved in PBS with PPG-20 methyl glucose ether buffer (PBSP:
0.02 M PBS, 2.7 mM KCl, 137 mM NaCl, 0.05% Surfactant P20, pH 7.4), diluted to a concentration series, and injected starting
from the lowest concentration. In all experiments, the analysis was performed at 25C, defining an association time of 60 s and a
dissociation time of 120 s at a flow of 30 mL /min. For calculating related ka, kd, and KD values,the Biacore T200 evaluation software
2.0 (GE Healthcare) was used and 0 mM was used for fitting the curve by a Langmuir 1:1 stoichiometric algorithm.
cADPR hydrolase activity of HEK293 lysate
The assay was conducted as previously described (Fang et al., 2018). Briefly, HEK293 cells and the CD38-overexpressing (CD38OE)
HEK293 cells were lysed with lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, pH 7.4, protease inhibitors
cocktail (Roche)). The endogenous nucleotides in the lysate were removed by dilution with centricon (Millipore, #MA54455).
150 mg total proteins were incubated with 0.4 mM cADPR in 100 mL of PBS for different time assays (0, 0.5, 1, 2 h). The reactants
were diluted in 1 mL of 5 mM trifluoroacetic acid (TFA) and applied to HPLC analysis (see HPLC part).e3 Cell Reports 27, 3684–3695.e1–e4, June 18, 2019
Immunostaining and flow cytometry
HEK293 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS)
supplemented with 1% penicillin-streptomycin. 5 3 105 cells were transfected with 2 mg pcDNA3.1-CD38 or pCMV3-CD157 using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. After 48 h post-transfection, cells were detached by
brief incubation with low concentration of trypsin (0.01%), which was safe for CD38 and CD157 proteins. 8 3 105 detached cells
were rinsed with PBS, fixed in 2% paraformaldehyde (PFA) at 4C for 15 min, washed and applied to staining process. For CD38
staining, cells were incubated in 1 mg/ml fluorescein isothiocyanate-labeled anti-CD38 (IB4)/BSA/PBS at room temperature for
30min, washedwith PBS and analyzedwith aCytoFLEX flow cytometer (BeckmanCoulter). For CD157 staining, cells were incubated
in 0.5 mg/ml anti-CD157 at room temperature for 30 min, washed, incubated with fluorescent-labeled secondary antibody at room
temperature for 30 min and analyzed by flow cytometry.
Docking and MD simulation
Docking study and MD simulation were conducted as previously described (Yu et al., 2017). In brief, the induced-fit docking (IFD)
protocol in Glide was used (Friesner et al., 2004). The receptor-ligand complexes were found in the preliminary docking step and
energy minimized to an induced-fit conformation. Then, induced docking was performed for cADPR within the NUDT9-H domain
of human TRPM2 with an 18 3 18 3 18–A˚ cube. The structure of cADPR interacting with the NUDT9-H domain produced by the
IFD procedure was further explored with MD simulations, by using the AMBER 11 software suite (University of California, San
Francisco, San Francisco, CA). The general AMBER force field (gaff) and the ff99SB force field were used for the protein and ligand,
respectively. A 15-ns data production run was performed. The absolute binding free energy (DG binding) was then predicted by
applying the MM/GBSA approaches, using a total of 50 snapshots from 13–15 ns which were evenly extracted from the single
MD trajectory. To illustrate the interactions between each residue and cADPR, we performed MM/GBSA decomposition analysis,
all snapshots mentioned above were used.
cADPR hydrolase incubation
1 mg/mL reCD38was added into 100 mMcADPR dissolved in 50 mL ICS (147mMNaCl, 0.05 mMEGTA, 1mMMgCl2, 10mMHEPES,
pH 7.3) and incubated at room temperature. The concentrations of cADPR and ADPR were determined using HPLC before and after
incubation (see HPLC part).
QUANTIFICATION AND STATISTICAL ANALYSIS
Prism 6 software (GraphPad Software) was used for all statistical analyses. Electrophysiological recordings from at least four cells or
independent parallel experiments were averaged and are presented in the text and figures as means ± SEM. Currents of the mutants
were normalized with themeanmaximal currents in cells expressing theWT TRPM2 channels recorded on the same day, which were
referred to as the relative currents. Student’s t test was applied to determine the significance of differences, except as otherwise
indicated. Mann-Whitney U test was carried out to determine the significance of differences on channel open probability in the single
channel recordings. p < 0.05 was considered to be statistically significant.Cell Reports 27, 3684–3695.e1–e4, June 18, 2019 e4
